Posted On: 06/01/2016 4:11:36 PM
Post# of 23064
$EBIO
On May 31, 2016 , Eleven Biotherapeutics, Inc. (the "Company"
received notification from the NASDAQ Listing Qualifications Department that for 10 consecutive business days, from May 16, 2016 to May 27, 2016 , the closing bid price of the Company's common stock was at $1.00 per share or greater and that, as a result, the Company has regained compliance with NASDAQ Listing Rule 5450(a)(1), which requires the Company to maintain the minimum bid price of $1.00 per share. The Company previously had received a notice on March 3, 2016 indicating its failure to meet the continued listing requirement for minimum bid price for a period of 30 consecutive business days, and was given 180 calendar days to regain compliance.
On May 31, 2016 , Eleven Biotherapeutics, Inc. (the "Company"
received notification from the NASDAQ Listing Qualifications Department that for 10 consecutive business days, from May 16, 2016 to May 27, 2016 , the closing bid price of the Company's common stock was at $1.00 per share or greater and that, as a result, the Company has regained compliance with NASDAQ Listing Rule 5450(a)(1), which requires the Company to maintain the minimum bid price of $1.00 per share. The Company previously had received a notice on March 3, 2016 indicating its failure to meet the continued listing requirement for minimum bid price for a period of 30 consecutive business days, and was given 180 calendar days to regain compliance.
(0)
(0)
